Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer

Prasad left the agency after far-right influencer released edited audio misleadingly suggesting he was anti-Trump

Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency.

At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research," Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters.